GBX insider Kelly M. Williams granted 2,511 restricted stock units
Rhea-AI Filing Summary
Kelly M. Williams, a director of The Greenbrier Companies (GBX), reported the automatic acquisition of 2,511 restricted stock units (RSUs) on 08/07/2025. The award arose from dividend equivalent rights tied to prior restricted stock grants and shows a $0.00 conversion price; each RSU represents a contingent right to receive one share of GBX common stock.
The additional time-based RSUs will vest on the earlier of the first anniversary of the underlying grant or the date of the next annual shareholder meeting and are recorded as direct beneficial ownership. Table II records the transaction with a transaction code indicating an acquisition (A). No purchases or sales of non-derivative common stock were reported on this Form 4; the filing was submitted by an attorney-in-fact on behalf of the reporting director.
Positive
- None.
Negative
- None.
Insights
TL;DR: Routine time-based RSU grant to a director; increases direct equity exposure but is non-cash and typical for compensation plans.
The Form 4 documents an automatic grant of 2,511 RSUs to director Kelly M. Williams, recorded as an acquisition in Table II with a $0.00 conversion price. Because each RSU converts to one share upon vesting, the award raises direct beneficial ownership once vested. This filing shows a compensation-related derivative transaction rather than an open-market purchase or sale, suggesting no immediate cash flow impact for the reporting person and no dilution details provided in this form.
TL;DR: Governance-standard equity award: dividend-equivalent RSUs vesting within a year, consistent with executive/director compensation practices.
The disclosure specifies that the award stems from dividend equivalent rights on existing restricted stock units and vests on the earlier of the first anniversary of the underlying grant or the next annual meeting. The grant is recorded as direct beneficial ownership of 2,511 RSUs. This is a routine administration of equity compensation for a director and is documented via an attorney-in-fact signature on the Form 4.